Search

Apc001

Apc001 is an aptamer developed for the treatment of osteogenesis imperfecta.

HLX-58

HLX-58 is an investigational monoclonal antibody targeted against claudin 18.2.

BA1301

BA1301 is an anti-Claudin18.2 monoclonal antibody conjugated with Duostatin-5.

DNB-001

In preclinical animal models, DNB-001 has demonstrated potent IOP- lowering effects as well as neuroprotective effects on the optic nerve. … DNB-001 is a first-in-class oral therapy with dual mechanism of action, which is initially being developed for the treatment of glaucoma.

Vasomera

Bethanidine

A guanidinium antihypertensive agent that acts by blocking adrenergic transmission.

Brasofensine

Brasofensine is an orally administered dopamine reuptake inhibitor being developed for the treatment of Parkinson's Disease. Phase I/II trials for brasofensine have been completed in the U.K.

Alethine

It belongs to a family of chemicals called disulfides. It is a low molecular weight disulfide that has been shown to exhibit in vivo antitumor activity in murine myeloma and melanoma models.

Hu-rhEGF-rP64k/Mont

Hu-rhEGF-rP64k/Mont is a therapeutic vaccine composed by an antigen (recombinant human EGF (rhEGF) chemically conjugated to recombinant P64K (rP64K)) and an adjuvant (Montanide ISA51VG) being investigated

Diethyltryptamine

Diethyltryptamine (DET) is an orally active hallucinogenic agent and a substituted form of tryptamine.